Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s10549-008-0193-0.

Title:
Use of antioxidant supplements during breast cancer treatment: a comprehensive review | Breast Cancer Research and Treatment
Description:
Purpose An estimated 45–80% of breast cancer patients use antioxidant supplements after diagnosis, and use of antioxidant supplements during breast cancer treatment is common. Dietary supplements with antioxidant effects include vitamins, minerals, phytonutrients, and other natural products. We conducted a comprehensive review of literature on the associations between antioxidant supplement use during breast cancer treatment and patient outcomes. Methods Inclusion criteria were: two or more subjects; clinical trial or observational study design; use of antioxidant supplements (vitamin C, vitamin E, antioxidant combinations, multivitamins, glutamine, glutathione, melatonin, or soy isoflavones) during chemotherapy, radiation therapy, and/or hormonal therapy for breast cancer as exposures; treatment toxicities, tumor response, recurrence, or survival as outcomes. Results We identified 22 articles that met those criteria. Their findings did not support any conclusions regarding the effects of individual antioxidant supplements during conventional breast cancer treatment on toxicities, tumor response, recurrence, or survival. A few studies suggested that antioxidant supplements might decrease side effects associated with treatment, including vitamin E for hot flashes due to hormonal therapy and glutamine for oral mucositis during chemotherapy. Underpowered trials suggest that melatonin may enhance tumor response during treatment. Conclusion The evidence is currently insufficient to inform clinician and patient guidelines on the use of antioxidant supplements during breast cancer treatment. Thus, well designed clinical trials and observational studies are needed to determine the short- and long-term effects of such agents.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {πŸ“š}

  • Health & Fitness
  • Education
  • Science

Content Management System {πŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {πŸ’Έ}

We're unsure how the site profits.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {πŸ”}

cancer, google, scholar, pubmed, breast, article, cas, patients, treatment, antioxidant, study, chemotherapy, therapy, supplements, clin, oncol, antioxidants, trial, med, effects, vitamin, radiation, review, randomized, medicine, health, alternative, women, greenlee, melatonin, survival, data, research, clinical, oral, res, treat, ther, toxicity, simone, receiving, privacy, cookies, content, hershman, jacobson, dietary, complementary, altern, doijco,

Topics {βœ’οΈ}

month download article/chapter american cancer society intensive dose-dense compared weekly low-dose epirubicin high-dose alpha-tocopherol high-dose adjuvant chemotherapy full article pdf breast cancer survivorship beta-carotene supplements phase ii study metastatic breast cancer metastatic breast cancer privacy choices/manage cookies alternative therapies living study group large fraction surviving placebo-controlled trial cancer endocrine therapy hormonal therapy high-dose tocopherol breast cancer patients breast cancer risk breast cancer survivors early breast cancer anthracycline cardiac toxicity historical cohort study barton dl nutritional antioxidants neck cancer patients mega-dose vitamins long-term effects breast cancer treatment san francisco ca nurses’ health study breast cancer diagnosis advanced solid neoplasms individual antioxidant supplements controlled clinical trial current health behaviors randomized controlled trials breast cancer recurrence prevent alopecia induced prospective randomized trial european economic area underpowered trials suggest tissue oxidative stress free radical generation gonzalez larriba jl acute cardiac toxicity apparent partial remission

Questions {❓}

  • Lawenda BD, Kelly KM, Ladas EJ et al (2008) Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Use of antioxidant supplements during breast cancer treatment: a comprehensive review
         description:Purpose An estimated 45–80% of breast cancer patients use antioxidant supplements after diagnosis, and use of antioxidant supplements during breast cancer treatment is common. Dietary supplements with antioxidant effects include vitamins, minerals, phytonutrients, and other natural products. We conducted a comprehensive review of literature on the associations between antioxidant supplement use during breast cancer treatment and patient outcomes. Methods Inclusion criteria were: two or more subjects; clinical trial or observational study design; use of antioxidant supplements (vitamin C, vitamin E, antioxidant combinations, multivitamins, glutamine, glutathione, melatonin, or soy isoflavones) during chemotherapy, radiation therapy, and/or hormonal therapy for breast cancer as exposures; treatment toxicities, tumor response, recurrence, or survival as outcomes. Results We identified 22 articles that met those criteria. Their findings did not support any conclusions regarding the effects of individual antioxidant supplements during conventional breast cancer treatment on toxicities, tumor response, recurrence, or survival. A few studies suggested that antioxidant supplements might decrease side effects associated with treatment, including vitamin E for hot flashes due to hormonal therapy and glutamine for oral mucositis during chemotherapy. Underpowered trials suggest that melatonin may enhance tumor response during treatment. Conclusion The evidence is currently insufficient to inform clinician and patient guidelines on the use of antioxidant supplements during breast cancer treatment. Thus, well designed clinical trials and observational studies are needed to determine the short- and long-term effects of such agents.
         datePublished:2008-10-07T00:00:00Z
         dateModified:2008-10-07T00:00:00Z
         pageStart:437
         pageEnd:452
         sameAs:https://doi.org/10.1007/s10549-008-0193-0
         keywords:
            Breast cancer
            Antioxidant supplements
            Complementary and alternative medicine
            Chemotherapy
            Radiation therapy
            Hormonal therapy
            Oncology
         image:
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:115
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Heather Greenlee
               affiliation:
                     name:Columbia University
                     address:
                        name:Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA
                        type:PostalAddress
                     type:Organization
                     name:Columbia University
                     address:
                        name:Herbert Irving Comprehensive Cancer Center, Columbia University, New York, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Dawn L. Hershman
               affiliation:
                     name:Columbia University
                     address:
                        name:Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA
                        type:PostalAddress
                     type:Organization
                     name:Columbia University
                     address:
                        name:Herbert Irving Comprehensive Cancer Center, Columbia University, New York, USA
                        type:PostalAddress
                     type:Organization
                     name:Columbia University
                     address:
                        name:Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Judith S. Jacobson
               affiliation:
                     name:Columbia University
                     address:
                        name:Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA
                        type:PostalAddress
                     type:Organization
                     name:Columbia University
                     address:
                        name:Herbert Irving Comprehensive Cancer Center, Columbia University, New York, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Use of antioxidant supplements during breast cancer treatment: a comprehensive review
      description:Purpose An estimated 45–80% of breast cancer patients use antioxidant supplements after diagnosis, and use of antioxidant supplements during breast cancer treatment is common. Dietary supplements with antioxidant effects include vitamins, minerals, phytonutrients, and other natural products. We conducted a comprehensive review of literature on the associations between antioxidant supplement use during breast cancer treatment and patient outcomes. Methods Inclusion criteria were: two or more subjects; clinical trial or observational study design; use of antioxidant supplements (vitamin C, vitamin E, antioxidant combinations, multivitamins, glutamine, glutathione, melatonin, or soy isoflavones) during chemotherapy, radiation therapy, and/or hormonal therapy for breast cancer as exposures; treatment toxicities, tumor response, recurrence, or survival as outcomes. Results We identified 22 articles that met those criteria. Their findings did not support any conclusions regarding the effects of individual antioxidant supplements during conventional breast cancer treatment on toxicities, tumor response, recurrence, or survival. A few studies suggested that antioxidant supplements might decrease side effects associated with treatment, including vitamin E for hot flashes due to hormonal therapy and glutamine for oral mucositis during chemotherapy. Underpowered trials suggest that melatonin may enhance tumor response during treatment. Conclusion The evidence is currently insufficient to inform clinician and patient guidelines on the use of antioxidant supplements during breast cancer treatment. Thus, well designed clinical trials and observational studies are needed to determine the short- and long-term effects of such agents.
      datePublished:2008-10-07T00:00:00Z
      dateModified:2008-10-07T00:00:00Z
      pageStart:437
      pageEnd:452
      sameAs:https://doi.org/10.1007/s10549-008-0193-0
      keywords:
         Breast cancer
         Antioxidant supplements
         Complementary and alternative medicine
         Chemotherapy
         Radiation therapy
         Hormonal therapy
         Oncology
      image:
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:115
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Heather Greenlee
            affiliation:
                  name:Columbia University
                  address:
                     name:Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA
                     type:PostalAddress
                  type:Organization
                  name:Columbia University
                  address:
                     name:Herbert Irving Comprehensive Cancer Center, Columbia University, New York, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Dawn L. Hershman
            affiliation:
                  name:Columbia University
                  address:
                     name:Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA
                     type:PostalAddress
                  type:Organization
                  name:Columbia University
                  address:
                     name:Herbert Irving Comprehensive Cancer Center, Columbia University, New York, USA
                     type:PostalAddress
                  type:Organization
                  name:Columbia University
                  address:
                     name:Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Judith S. Jacobson
            affiliation:
                  name:Columbia University
                  address:
                     name:Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA
                     type:PostalAddress
                  type:Organization
                  name:Columbia University
                  address:
                     name:Herbert Irving Comprehensive Cancer Center, Columbia University, New York, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:115
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Columbia University
      address:
         name:Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA
         type:PostalAddress
      name:Columbia University
      address:
         name:Herbert Irving Comprehensive Cancer Center, Columbia University, New York, USA
         type:PostalAddress
      name:Columbia University
      address:
         name:Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA
         type:PostalAddress
      name:Columbia University
      address:
         name:Herbert Irving Comprehensive Cancer Center, Columbia University, New York, USA
         type:PostalAddress
      name:Columbia University
      address:
         name:Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, USA
         type:PostalAddress
      name:Columbia University
      address:
         name:Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA
         type:PostalAddress
      name:Columbia University
      address:
         name:Herbert Irving Comprehensive Cancer Center, Columbia University, New York, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Heather Greenlee
      affiliation:
            name:Columbia University
            address:
               name:Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA
               type:PostalAddress
            type:Organization
            name:Columbia University
            address:
               name:Herbert Irving Comprehensive Cancer Center, Columbia University, New York, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Dawn L. Hershman
      affiliation:
            name:Columbia University
            address:
               name:Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA
               type:PostalAddress
            type:Organization
            name:Columbia University
            address:
               name:Herbert Irving Comprehensive Cancer Center, Columbia University, New York, USA
               type:PostalAddress
            type:Organization
            name:Columbia University
            address:
               name:Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, USA
               type:PostalAddress
            type:Organization
      name:Judith S. Jacobson
      affiliation:
            name:Columbia University
            address:
               name:Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA
               type:PostalAddress
            type:Organization
            name:Columbia University
            address:
               name:Herbert Irving Comprehensive Cancer Center, Columbia University, New York, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA
      name:Herbert Irving Comprehensive Cancer Center, Columbia University, New York, USA
      name:Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA
      name:Herbert Irving Comprehensive Cancer Center, Columbia University, New York, USA
      name:Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, USA
      name:Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA
      name:Herbert Irving Comprehensive Cancer Center, Columbia University, New York, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {πŸ”—}(187)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Foundation
  • Prism.js

CDN Services {πŸ“¦}

  • Crossref

5.03s.